The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.
An updated KFF analysis finds that counties that voted for Biden continue to have higher COVID-19 vaccination rates compared to counties that voted for Trump. As of January 11, 65% of those in Biden counties were fully vaccinated versus 52% of those in Trump counties.
This analysis from the KFF COVID-19 Vaccine Monitor explores the public's response to the news about the omicron variant of coronavirus, and finds that while it may convince vaccinated adults to get their COVID-19 booster vaccine, unvaccinated adults are largely unmoved by the news.
About a Third of the Public Thinks the Nation is Facing a New COVID-19 Wave as Cases Rise About a fifth (18%) of parents with children under age 5 say they intend to get their child vaccinated “right away” once federal regulators authorize its use for their child’s age group, the latest KFF COVID-19 Vaccine…
Providing paid time off to employees to get and recover from any side effects could help boost vaccination rates. Overall, nearly three in ten (28%) employed adults who not yet ready to get the vaccine say that they would be more likely to get the COVID-19 vaccine if their employer gave them paid time off to get vaccinated and recover from any side effects.
As of April 19, COVID-19 vaccine eligibility opened up to adults in all states, leaving many to wonder when supply will surpass vaccine demand. A recent brief examined when COVID-19 vaccine supply might outstrip demand in the U.S. nationally, estimating that the U.S. will reach this point within a few weeks.
Around the country and in parts of the world, COVID-19 vaccination efforts continue to grow, leaving people wondering about vaccine requirements and ways to certify vaccine status.
This issue brief builds on a previous CDC analysis by analyzing how vaccination rates to date vary by counties and identifying key county characteristics that are associated with higher or lower county vaccination rates.
This volume shares findings from the latest KFF Tracking Poll on Health Information and Trust, along with updates from Robert Kennedy Jr’s senate hearings. It also examines distrust in public health messaging about bird flu, motivations for sharing information online, and how fraudulent research can sometimes inform AI chatbot models.
As Senate hearings begin for President Trump’s health nominees, including Robert F. Kennedy Jr., the latest KFF Tracking Poll on Health Information and Trust shows a decline in public trust for government health agencies like the CDC, FDA, and local public health officials. The poll reveals growing skepticism about vaccines and school vaccine requirements, especially among Republicans and parents, while misinformation about vaccine safety persists. Despite low concern about the H5N1 bird flu, the U.S. public is divided on how prepared they believe the government is for future health crises or pandemic.
© 2026 KFF